Wells Fargo & Company T2 Biosystems, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.09 - $565.0 $0 - $1,695	-3 Reduced 0.26%	1,142 $0
Q2 2022 Aug 12, 2022	SELL	$0.15 - $0.54 $431 - $1,553	-2,877 Reduced 71.53%	1,145 $0
Q1 2022 May 16, 2022	BUY	$0.36 - $0.57 $1 - $2	4 Added 0.1%	4,022 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.46 - $0.94 $626 - $1,279	1,361 Added 51.22%	4,018 $3,000
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $3,155 - $4,439	-3,669 Reduced 58.0%	2,657 $3,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.69 $4,375 - $7,109	4,207 Added 198.54%	6,326 $7,000
Q1 2021 May 13, 2021	SELL	$1.32 - $3.79 $207,905 - $596,940	-157,504 Reduced 98.67%	2,119 $4,000
Q4 2020 Feb 09, 2021	BUY	$1.06 - $1.51 $60,890 - $86,740	57,444 Added 56.22%	159,623 $198,000
Q3 2020 Nov 05, 2020	SELL	$1.15 - $2.1 $94,372 - $172,332	-82,063 Reduced 44.54%	102,179 $139,000
Q2 2020 Aug 13, 2020	BUY	$0.48 - $1.67 $64,250 - $223,539	133,856 Added 265.66%	184,242 $234,000
Q1 2020 May 14, 2020	BUY	$0.28 - $1.23 $14,108 - $61,974	50,386 New	50,386 $33,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.